US56565P1030
US56565P1030
MapLight Therapeutics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 490.73M EUR | 1.63B EUR | 919.1M EUR | 773.28M EUR |
Enterprise Value | 121.62M EUR | 1.56B EUR | 868.98M EUR | 732.36M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -2.58x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 1.15x | 4.68x | 2.3x | 1.69x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -0.5x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -19.4% | -10.75% | -14.17% | -10.22% |